Over the past six months, Oscar Health’s stock price fell to $13.90. Shareholders have lost 19.7% of their capital, which is disappointing considering the S&P 500 has climbed by 5%. This may have investors wondering how to approach the situation.
A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending shockwaves across the health insurance sector.
Oscar Health, Inc. (NYSE:OSCR) stands as a disruptive force in the American health insurance landscape, emerging as a pioneer at the crossroads of technology and healthcare. Since its inception in 2012, Oscar Health has sought to simplify, personalize, and digitize the insurance experience, aiming to reshape a sector often
Oscar Health has once again asserted itself as a formidable disruptor in the insurance sector, with its stock posting robust gains after the company exceeded Wall Street’s expectations. The latest quarterly results for Oscar Health (NYSE:OSCR) showcased not only improving financial fundamentals but also a growing footprint in
Global financial markets are poised at a critical juncture as a confluence of high-impact corporate earnings releases and key macroeconomic indicators is expected to shape the investment climate for the second half of the year. With major equity indices such as the S&P 500 hovering near record highs, investors
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 3.1% in the morning session after the stock continued a sharp decline from the previous session, which was fueled by multiple analyst downgrades and broader weakness in the healthcare plans sector.
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 5% in the afternoon session after Wells Fargo downgraded the stock and slashed its price target. The financial institution lowered its rating on the health insurer to "Underweight" from "Equal Weight" and cut its price target to $10 from $16.
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at CVS Health (NYSE:CVS) and its peers.
